New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 12, 2012
23:40 EDTSLE, GLD, KORS, WPRT, DRI, CMG, RNDY, AUQ, P, ESRX, STO, BEAM, COV, AGN, CELG, HD, TSCO, TITN, SHW, CHKJim Cramer's "Mad Money"
Jim Cramer said, "2012 is no longer about global economic crisis, it's about buying stock in the companies you love." Cramer said he's no longer sweating the details of every story that hits the news wires. Because the big-money players, those who would sell on every bit of negative news, are simply no longer a part of this market. They have been replaced by good old-fashioned individual investors. When companies break up, investors win, Cramer reminded viewers, as he highlighted yet another corporate breakup story, Sara Lee (SLE). He said that shares of Sara Lee should follow in the footsteps of Beam (BEAM) and Covidien (COV), two other breakup stocks, which headed markedly higher. Sara Lee is offering a $3-a-share special dividend to shareholders when the breakup occurs. Additionally, recent analysis of Sara Lee's various components values the stock 22% higher than where it trades today. Sara Lee plans to update shareholders on its progress at an investors meeting on June 5. Investing in Sara Lee will be a slow climb, said Cramer, which is why he would use recent weakness in the stock to get in at attractive prices. Continuing with his week-long series of great American growth stocks, Cramer turned the spotlight onto Allergan (AGN). It is not only a health care company that treats eye problems and migraines, but it is also a leader in medical aesthetics, including Botox and great implants. Cramer said that Allergan has multiple years of growth ahead of it. Its end markets are huge. Also, Allergan is highly competitive in every arena in which it enters and the company pays a tiny dividend. Shares trade for just 19x earnings and the company has a 14% long-term growth rate. Giving investors another great American growth stock, Cramer also highlighted Celgene (CELG), another stock just off its 52-week high. Celgene has one of the fastest growth rates in its sector, said Cramer, and also huge market potential as a host of new products and new applications for existing products are chugging toward FDA approval. Internationally, the company is a powerhouse. Cramer said that while Celgene is unlikely to offer a dividend anytime soon, the company has done a few well-timed stock buybacks to reward shareholders. Celgene sports a rock-solid balance sheet. Celgene trades at just 13.8x next year's earnings, despite the company's 24% growth rate. NO HUDDLE OFFENSE: Cramer said that the tailwinds are all lining up for a great quarter at Home Depot (HD), and he would be a buyer of the stock, even up near its 52-week high. Case-in-point: Tractor Supply (TSCO) announced sales that are double what analysts are expecting and Titan Machinery (TITN) pre-announced strong earnings, followed by Sherwin-Williams (SHW) announcing sales up by 20%. LIGHTNING ROUND: (Bullish) STO; ESRX; GLD; KORS; WPRT; DRI; CMG; RNDY. (Bearish) AUQ; P; CHK. Reference Link
News For SLE;BEAM;COV;AGN;CELG;HD;TSCO;TITN;SHW;STO;ESRX;GLD;KORS;WPRT;DRI;CMG;RNDY;AUQ;P;CHK From The Last 14 Days
Check below for free stories on SLE;BEAM;COV;AGN;CELG;HD;TSCO;TITN;SHW;STO;ESRX;GLD;KORS;WPRT;DRI;CMG;RNDY;AUQ;P;CHK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
August 18, 2014
16:00 EDTHDOptions Update; August 18, 2014
Subscribe for More Information
15:59 EDTAGNAllergan CFO change may suggest strategic deal near, says BMO Capital
BMO Capital believes former Allergan (AGN) CFO Jeff Edwards would not be leaving if a change of control of the company, such as a takeover by Valeant (VRX), were in the future. Rather, BMO thinks Edwards' decision to leave could be a sign that a strategic transaction marking a new chapter in Allergan's growth may be nearing. The firm thinks Allergan is in capable hands with new CFO Jim Hindman and it keeps an Outperform rating on the stock with a $230 price target.
15:26 EDTHDNotable companies reporting before tomorrow's open
Subscribe for More Information
14:49 EDTHDHome Depot August weekly 83.5 straddle priced for 2.3% move into Q2
14:32 EDTHDHome Depot technical notes ahead of earnings
Subscribe for More Information
14:22 EDTHDHome Depot technical notes ahead of earnings
Subscribe for More Information
14:14 EDTHDHome Depot technical notes ahead of earnings
Subscribe for More Information
11:57 EDTAGNAllergan CFO departure largely unexpected, says Wells Fargo
Subscribe for More Information
11:39 EDTHDHome Depot weekly volatility elevated into Q2 and outlook
Subscribe for More Information
11:25 EDTTSCO, HDEarnings Preview: Home Depot shares up nearly 9% since last earnings report
Home Depot (HD), a home improvement retailer, is scheduled to report second quarter results before the market opens on Tuesday, August 19, with a conference call scheduled for 9:00 am ET. EXPECTATIONS: Analysts are looking for earnings per share of $1.45 on revenue of $23.62B, according to First Call. The consensus range for EPS is $1.41-$1.49 on revenue of $22.9B-$24.08B. LAST QUARTER: Home Depot reported first quarter EPS of $1.00 against estimates for 99c on revenue of $19.69B against estimates of $19.95B. The company said same-store sales increased 2.6%, with U.S. SSS up 3.3%. The company raised its fiscal year 2014 EPS view to $4.42 from $4.38 against estimates at that time for $4.42. The retailer also backed its FY14 sales growth view of up 4.8% from fiscal year 2013. On its Q4 earnings conference call, Home Depot forecast gross margins for FY14 would be "about the same" as last year. For the remainder of the year, the company said its view on the housing market recovery had not changed. NEWS: At Oppenheimer's 14th Annual Consumer Conference in June, Home Depot reaffirmed its 4.8% sales growth view for the year and said SSS growth would be 4.6%. The company also said it expected $7B in share repurchases for FY14. The retailer also said it intends to increase its dividend every year. The Wall Street Journal said Home Depot is among the retailers betting that consumer basics, like toilet paper or detergent, will increase sales and lure shoppers into stores. STREET RESEARCH: Citigroup expects Home Depot shares will continue outperforming Lowe's (LOW) in the near-term given its store base concentration and better merchandising effort on the Pro side. Deutsche Bank lowered its estimates for both Home Depot after Tractor Supply (TSCO) and Lumber Liquidators (LL) pre-announced Q2 comp misses. The firm, which noted that the negative earnings revision is "relatively minor," said that while the business models are different, Tractor Supply and Lumber Liquidators have historically correlated positively with Home Depot and Lowe's on comps. PRICE ACTION: Over the last three months, Home Depot shares are up almost 9%. Year-to-date, shares are up over 2%.
09:02 EDTAGNAllergan names Jim Hindman as CFO, effective immediately
Subscribe for More Information
07:57 EDTAGNCambridge Healthtech Institute to hold a summit
6th Annual Bioprocessing Summit to be held in Boston on August 18-22.
06:44 EDTCHKNatural gas companies worried about regulatory outlook, The Hill says
Subscribe for More Information
06:24 EDTHDOptions expected to be active
Subscribe for More Information
06:13 EDTGLDSPDR Gold Trust overall implied volatility at 13; 26-week average is 15
August 15, 2014
17:03 EDTAGNValeant extends offer to acquire Allergan
Valeant Pharmaceuticals (VRX) announced that it has extended the expiration of its exchange offer to acquire all of the outstanding shares of Allergan (AGN) to December 31. The exchange offer was previously scheduled to expire August 15. All other terms and conditions of the exchange offer remain unchanged.
14:14 EDTAGNValeant being probed by IRS after Biovail deal, FT says
Subscribe for More Information
09:45 EDTAGNEvent-driven funds, Pershing own over 20% of Allergan, CNBC reports
Event-driven hedge funds and Pershing Square owned over 20% of Allergan as of June 30, CNBC's David Faber reports. Valeant (VRX) and Pershing are seen as getting the over 30% to call a special meeting, Faber adds.
09:03 EDTDRIDarden retains Russell Reynolds for CEO search
Subscribe for More Information
05:57 EDTGLDSPDR Gold Trust overall implied volatility at 13; 26-week average is 15
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use